Nova Newborn Metabolic Disorders Screening at Chughtai Lab

Nova Newborn Metabolic Disorders Screening (Hongkong) at Chughtai Lab

The Nova Newborn Metabolic Disorders Screening (Hongkong) at Chughtai Lab is a premier, highly specialized diagnostic panel designed to identify a broad spectrum of inborn errors of metabolism (IEMs) and congenital disorders in newborn infants. This advanced screening represents a vital preventive healthcare protocol, performed shortly after birth, to detect metabolic anomalies before clinical symptoms manifest. Many congenital metabolic disorders are clinically silent at birth; infants appear perfectly healthy but lack specific enzymes required to process proteins, carbohydrates, or fats. If left undetected and untreated, these metabolic deficits can lead to rapid, irreversible neurological damage, severe physical developmental delays, cognitive impairment, or life-threatening metabolic crises. By utilizing state-of-the-art diagnostic technologies, including Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS), this screening panel analyzes a tiny sample of blood to identify biochemical markers indicative of genetic disorders. Early detection through this comprehensive panel allows pediatricians and metabolic specialists to initiate immediate therapeutic interventions, such as specialized dietary regimens, enzyme replacement therapies, or cofactor supplementations. These early interventions can completely alter the clinical course of the disease, enabling affected children to lead healthy, normal lives. Chughtai Lab, Pakistan’s leading diagnostic network, offers this advanced screening to ensure that families across the country have access to world-class neonatal preventive care.

Clinical Procedure: What to Expect

Patient Preparation

Preparing a newborn for the Nova Newborn Metabolic Disorders Screening (Hongkong) is straightforward but requires careful adherence to clinical guidelines to ensure accurate results. The following preparation steps are recommended:

• Timing of the Test: The ideal window for sample collection is between 24 and 72 hours after birth. This timeline ensures that the infant has ingested sufficient milk to activate metabolic pathways, allowing for the accurate detection of amino acid and carbohydrate processing disorders.
• Feeding Requirements: The infant should have had at least one or two successful milk feeds (either breast milk or formula) prior to the test. Fasting is not required or recommended for newborns undergoing this screening.
• Documentation: Parents should provide complete clinical details, including the exact time of birth, gestational age, birth weight, feeding history, and any family history of metabolic or genetic disorders.
• Avoid Contaminants: Ensure the infant’s heel is clean and free from topical creams, oils, or powders before the procedure.

During the Procedure

The sample collection process is designed to be quick, safe, and minimally invasive for the newborn. It is performed by highly trained pediatric phlebotomists at Chughtai Lab who specialize in neonatal care:

• Sanitization and Warming: The phlebotomist will first warm the infant’s heel gently using a warm compress or manual massage. This increases localized capillary blood flow, ensuring a smooth collection process. The heel is then thoroughly sanitized with an antiseptic swab and allowed to air dry completely.
• The Heel Prick: A sterile, single-use, automated safety lancet is used to perform a shallow puncture on the lateral or medial plantar surface of the heel. This specific anatomical site is chosen to avoid hitting the calcaneus (heel bone), ensuring maximum safety and minimal discomfort.
• Sample Collection: The first drop of blood is gently wiped away with sterile gauze to prevent tissue fluid contamination. Subsequent drops of blood are allowed to flow naturally and are applied directly to designated circles on a specialized filter paper card (Guthrie card). The blood must fully saturate each circle from the front of the card to the back.
• Post-Procedure Care: Gentle pressure is applied to the puncture site with a sterile cotton ball until bleeding stops, and a small adhesive bandage may be applied. The infant can be immediately comforted, nursed, or held by the mother, which rapidly alleviates any minor distress.
• Sample Processing: The filter paper card is dried horizontally at room temperature for several hours before being securely packaged and transported under controlled conditions to the specialized laboratory for high-throughput analysis.

When is a Nova Newborn Metabolic Disorders Screening Performed?

Routine Universal Neonatal Screening

Physicians recommend the Nova Newborn Metabolic Disorders Screening as a routine preventive test for every newborn infant within the first few days of life. Because many metabolic disorders do not present visible symptoms immediately after birth, universal screening is the only reliable method to identify affected infants before permanent physiological damage occurs. Initiating the test during the asymptomatic phase allows for pre-emptive clinical management.

Family History of Genetic or Metabolic Disorders

If a family has a history of unexplained infant deaths, sudden infant death syndrome (SIDS), developmental delays, or confirmed inborn errors of metabolism, this screening is critically indicated. Genetic metabolic disorders are predominantly inherited in an autosomal recessive manner, meaning parents can be asymptomatic carriers. In such cases, early screening provides immediate diagnostic clarity and guides targeted therapeutic protocols.

Consanguinity in Parents

In regions like Pakistan, where consanguineous (cousin) marriages are culturally common, the risk of autosomal recessive genetic disorders is significantly elevated. Pediatricians strongly advise parents in consanguineous unions to opt for comprehensive newborn screening panels like the Nova screening. This proactive measure helps identify genetic anomalies early, mitigating the risks associated with inherited metabolic pathways.

Unexplained Neonatal Illness or Failure to Thrive

When a newborn exhibits unexplained clinical symptoms such as severe lethargy, poor feeding, persistent vomiting, metabolic acidosis, hypoglycemia, or seizures shortly after birth, physicians request this screening. These symptoms are classic indicators of an acute metabolic crisis triggered by the accumulation of toxic metabolites. The screening helps rapidly pinpoint the underlying enzyme deficiency, allowing for life-saving emergency medical interventions.

Early Detection of Inborn Errors of Metabolism (IEMs)

The primary clinical indication for this screening is the comprehensive evaluation of metabolic pathways. By assessing how the infant’s body metabolizes amino acids, organic acids, and fatty acids, the test assists physicians in diagnosing conditions like Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD), and Congenital Hypothyroidism. Early diagnosis ensures that treatment begins before physical or intellectual disabilities develop.

What Does a Nova Newborn Metabolic Disorders Screening Detect?

The Nova Newborn Metabolic Disorders Screening (Hongkong) is designed to detect a comprehensive array of metabolic, endocrine, and genetic conditions. These include:

• Amino Acid Disorders: Conditions like Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD), Homocystinuria, Tyrosinemia Type I, and Citrullinemia, where the body cannot break down specific amino acids, leading to toxic brain accumulation.
• Organic Acidemias: Disorders such as Methylmalonic Acidemia (MMA), Propionic Acidemia, Isovaleric Acidemia, and Glutaric Aciduria Type I, which cause a dangerous buildup of acidic compounds in the blood and tissues.
• Fatty Acid Oxidation Defects: Conditions including Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency, Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency, and Carnitine Palmitoyltransferase Deficiency, which prevent the body from converting fats into energy during periods of fasting or illness.
• Endocrine Disorders: Congenital Hypothyroidism (which can cause severe intellectual disability if untreated) and Congenital Adrenal Hyperplasia (CAH), which affects hormone production in the adrenal glands.
• Hemoglobinopathies: Abnormalities in hemoglobin structure, such as Sickle Cell Anemia and various forms of Thalassemia.
• Other Metabolic Conditions: Galactosemia (inability to process galactose sugar from milk), Biotinidase Deficiency (inability to recycle the vitamin biotin), and Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is committed to delivering highly accurate and timely diagnostic results. Because the Nova Newborn Metabolic Disorders Screening (Hongkong) involves highly specialized molecular and mass spectrometry analyses, the processing time is managed with strict quality control protocols. Typically, results are compiled and verified by expert clinical pathologists within a specified turnaround time. Parents can easily access their child’s diagnostic reports online through the official Chughtai Lab website or the dedicated Chughtai Lab mobile application. Additionally, reports can be received via WhatsApp or collected physically from any of the numerous Chughtai Lab collection centers located across Lahore, Karachi, Islamabad, and other major cities in Pakistan. Prompt reporting ensures that pediatricians can review the findings immediately and initiate clinical management if any abnormalities are detected.

Nova Newborn Metabolic Disorders Screening Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Phenylalanine Levels	Within normal physiological limits for age	Elevated levels (indicative of Phenylketonuria)
Leucine & Isoleucine	Normal concentration in dried blood spot	Elevated levels (indicative of Maple Syrup Urine Disease)
Thyroid Stimulating Hormone (TSH)	Normal range for neonates	Elevated TSH (indicative of Congenital Hypothyroidism)
17-Hydroxyprogesterone (17-OHP)	Within standard neonatal reference limits	Elevated levels (suggestive of Congenital Adrenal Hyperplasia)
Galactose-1-Phosphate	Normal enzymatic activity and levels	Elevated levels (indicative of Galactosemia)
G6PD Enzyme Activity	Adequate enzyme activity detected	Deficient enzyme activity (G6PD Deficiency)
Acylcarnitine Profile	Normal distribution of short, medium, and long-chain acylcarnitines	Abnormal elevations (indicative of Fatty Acid Oxidation Defects or Organic Acidemias)
Biotinidase Activity	Normal enzyme activity present	Partial or complete deficiency of biotinidase enzyme

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Nova Newborn Metabolic Disorders Screening?

• Experienced Healthcare Professionals: Chughtai Lab employs highly qualified clinical pathologists, geneticists, and laboratory technologists who ensure the highest standards of diagnostic accuracy.
• Patient-Focused Care: Our dedicated pediatric phlebotomists are specially trained to handle newborns with extreme care, ensuring a gentle and stress-free sample collection experience.
• Quality Diagnostic Services: Chughtai Lab utilizes international reference standards and participates in rigorous external quality assurance programs to deliver reliable results.
• Professional Reporting: Reports are detailed, comprehensive, and include clear clinical interpretations to assist pediatricians in rapid decision-making.
• Modern Diagnostic Approach: The laboratory is equipped with state-of-the-art analytical platforms, including advanced Tandem Mass Spectrometry (LC-MS/MS) technology.
• Comfortable Environment: All Chughtai Lab diagnostic centers are designed to provide a clean, hygienic, and welcoming environment for families and infants.
• Convenient Location: With a vast network of collection centers across Pakistan, finding a Chughtai Lab facility near you is simple and convenient.
• Commitment to Accurate Diagnosis: Chughtai Lab is dedicated to providing timely, accurate, and actionable diagnostic insights to support early intervention and save newborn lives.